Friday , July 20 2018
Home / Letter From The Editor (page 5)

Letter From The Editor

March 10, 2018

I recently converted one of my aero road bikes from a 22-speed to a single speed, which means I only have one gear. I can still get up to 27 mph on a sprint, but instead of pedaling at 80 revolutions a minute, I am forced to pedal at 123 …

Read More »

March 8, 2018

The SGLT-2 inhibitors continue to garner headlines and scientific publications as our knowledge of how they work and what they can do increases. Part of the reason all this is happening at a rapid pace is the multiple brands available on the class. This means that endpoint studies can be …

Read More »

March 6, 2018

The pressures of reimbursement have taken their affect on the amount of time that a patient gets to spend with their clinician. This means that often there is no time for you to say everything to your patient that you would like to and that means that the obesity conversation …

Read More »

March 3, 2018

Many years ago, when Steve and I were first sending our newsletter to a few pharmacists, we realized we needed to offer more than any other diabetes newsletter. We were the new kids on the block; we weren’t journalists, but we were pharmacists. So we started to look for well-respected, …

Read More »

Feb. 27, 2018

For the past three years, I have been working with a Pharma company to build a network of independent pharmacies for prescribers to send their patients to. When we started this, the idea was simple — “send your patients to someone you would want to go to.” In the last …

Read More »

Feb. 24, 2018

Every week we bring you great information on the latest details of new drugs and new studies on old drugs. In fact in 2018 alone we have had over 20 articles on pharmaceuticals. This plethora of choices and information often overwhelms even the most astute clinician, and when you add …

Read More »

Feb. 20, 2018

There have been a lot of diseases associated with diabetes, and it is often said that, although it is never on the death certificate, diabetes is the biggest killer. We often can think of some of the common ones, like heart failure, stroke, and kidney failure. And other conditions that …

Read More »

Feb. 17, 2018

When I was working with endocrinologists they would often place their type one patients on metformin. I would share this with primary prescribers, and they too had good results using a type 2 drug for insulin dependent patients. We now have more choices than ever for patients and it only …

Read More »

Feb. 13, 2018

There seems to be a consensus amongst medical professionals and researchers that patients don’t want to test their glucose regardless of how bad their condition is. It appears that CGMS is the future according to a lot of experts. But is it feasible in the real world? This week, we …

Read More »

Feb. 10, 2018

As I was driving home the other night I heard a duet by Bette Midler and Barbra Streisand. The lyrics included “Anything you can do, I can do better; I can do anything better than you.” For some reason this got me thinking about the use of AI (artificial intelligence). …

Read More »